These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9923887)

  • 21. Higher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123--ETOILE).
    Avettand-Fenoel V; Bouteloup V; Mélard A; Fagard C; Chaix ML; Leclercq P; Chêne G; Viard JP; Rouzioux C;
    J Antimicrob Chemother; 2010 Oct; 65(10):2212-4. PubMed ID: 20667886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Strategies for combating resistances in HIV therapy--an exemplifying case].
    Stoehr A
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():70-1. PubMed ID: 15373056
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiretroviral rounds. CD4 count 423, viral load 12,000: time to treat anyway?
    Hodder S; Frank I
    AIDS Clin Care; 2006 Jun; 18(6):59-60. PubMed ID: 16791955
    [No Abstract]   [Full Text] [Related]  

  • 24. Monitoring treatment: at what cost?
    Cohen J
    Science; 2004 Jun; 304(5679):1936. PubMed ID: 15218140
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy.
    Mocroft A; Phillips AN; Ledergerber B; Smith C; Bogner JR; Lacombe K; Wiercinska-Drapalo A; Reiss P; Kirk O; Lundgren JD;
    Antivir Ther; 2010; 15(4):563-70. PubMed ID: 20587849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy of early HIV infection: time for the pendulum to swing back?
    Schechter M; Harrison LH
    AIDS Clin Care; 1999 Oct; 11(10):79-81, 86. PubMed ID: 11366705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
    Günthard HF; Wong JK; Spina CA; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman DD
    J Infect Dis; 2000 Feb; 181(2):522-31. PubMed ID: 10669335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression.
    Angel JB; Parato KG; Kumar A; Kravcik S; Badley AD; Fex C; Ashby D; Sun E; Cameron DW
    J Infect Dis; 2001 Feb; 183(4):546-54. PubMed ID: 11170979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
    Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
    J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
    J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fusion inhibitors. One year therapy with T-20--initial evaluation].
    Goebel FD
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():42-3. PubMed ID: 15373046
    [No Abstract]   [Full Text] [Related]  

  • 32. [New biological monitoring of HIV infection].
    Morand-Joubert L
    Rev Prat; 1998 Mar; 48(5):472-7. PubMed ID: 9781107
    [No Abstract]   [Full Text] [Related]  

  • 33. "When do I start?"; "what do I start with?"; and "when should I switch?".
    Laurence J
    AIDS Patient Care STDS; 1997 Jun; 11(3):121-3. PubMed ID: 11361784
    [No Abstract]   [Full Text] [Related]  

  • 34. [Not Available].
    Dialer I; Seybold U; Bogner J
    MMW Fortschr Med; 2015 Jun; 157 Suppl 2():33-5. PubMed ID: 26048118
    [No Abstract]   [Full Text] [Related]  

  • 35. Never say never to a cure for HIV-1 infection.
    Morris K
    Lancet; 1997 May; 349(9062):1371. PubMed ID: 9149709
    [No Abstract]   [Full Text] [Related]  

  • 36. The case for conservative management of early HIV disease.
    Burman WJ; Reves RR; Cohn DL
    JAMA; 1998 Jul; 280(1):93-5. PubMed ID: 9660372
    [No Abstract]   [Full Text] [Related]  

  • 37. Report from the Tenth Retrovirus Conference. New drugs.
    Sax PE
    AIDS Clin Care; 2003 Apr; 15(4):32-3. PubMed ID: 12712947
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid progression of CD4 cell decline and subsequent response to salvage therapy in HIV-2 infection.
    Houston SC; Miedzinski LJ; Mashinter LD
    AIDS; 2002 May; 16(8):1189-91. PubMed ID: 12004281
    [No Abstract]   [Full Text] [Related]  

  • 39. CD4 count/viral load in HIV.
    Hengel R
    Cytometry; 2000 Feb; 42(1):79-80. PubMed ID: 10679747
    [No Abstract]   [Full Text] [Related]  

  • 40. Interleukin 2 treatment for HIV infection.
    Blankson J; Siliciano RF
    JAMA; 2000 Jul; 284(2):236-8. PubMed ID: 10889599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.